Primary orbital peripheral T-cell lymphoma: histologic, immunophenotypic, and genotypic features.

1. McGuire TW, Bullock JD, Bullock JD Jr, Elder BL, Funkhouser JW. Fungal endophthalmitis: an experimental study with a review of 17 human ocular cases. Arch Ophthalmol. 1991;109(9): 1289-1296. 2. McKelvie PA, Wong EY, Chow LP, Hall AJ. Scedosporium endophthalmitis: two fatal disseminated cases of Scedosporium infection presenting with endophthalmitis. Clin Experiment Ophthalmol. 2001;29(5):330-334. 3. Figueroa MS, Fortun J, Clement A, De Arevalo BF. Endogenous endophthalmitis caused by Scedosporium apiospermum treated with voriconazole. Retina. 2004;24(2):319-320. 4. Maertens J, Lagrou K, Deweerdt H, et al. Disseminated infection by Scedosporium prolificans: an emerging fatality among haematology patients: case report and review. Ann Hematol. 2000;79(6):340-344. 5. Larocco A Jr, Barron JB. Endogenous Scedosporium apiospermum endophthalmitis. Retina. 2005; 25(8):1090-1093. 6. Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills MD, Grand MG. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol. 2005; 139(1):135-140. 7. Gao H, Pennesi ME, Shah K, et al. Intravitreal voriconazole: an electroretinographic and histopathologic study [published correction appears in Arch Ophthalmol. 2005;123(1):130]. Arch Ophthalmol. 2004;122(11):1687-1692. 8. Scott IU, Cruz-Villegas V, Flynn HW Jr, Miller D. Delayed-onset, bleb-associated endophthalmitis caused by Lecythophora mutabilis. Am J Ophthalmol. 2004;137(3):583-585. 9. Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis. 2003; 36(5):630-637.